(Q39568782)

13 September 2017

title

Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease (English)

1 reference

13 September 2017

Sarah Seiler

1

1 reference

13 September 2017

Ming Wen

2

1 reference

13 September 2017

Heinz J Roth

3

1 reference

13 September 2017

Michael Fehrenz

4

1 reference

13 September 2017

Franziska Flügge

5

1 reference

13 September 2017

Esther Herath

6

1 reference

13 September 2017

Anja Weihrauch

7

1 reference

13 September 2017

Danilo Fliser

8

1 reference

13 September 2017

Gunnar H Heine

9

1 reference

13 September 2017

language of work or name

English

0 references

publication date

15 August 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

83

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

121-128

1 reference

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Serum phosphate levels and mortality risk among people with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Chronic kidney disease, hypovitaminosis D, and mortality in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Vitamin D levels and patient outcome in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Vitamin D levels and early mortality among incident hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Klotho deficiency causes vascular calcification in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Role of Klotho in aging, phosphate metabolism, and CKD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Plasma klotho and mortality risk in older community-dwelling adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

FGF23 induces left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Circulating levels of soluble α-Klotho in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Soluble klotho and autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Statins ameliorate atherosclerosis induced by inhibition of nitric oxide synthase: another novel vascular protective mechanism?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Amelioration of progressive renal injury by genetic manipulation of Klotho gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.288

7 January 2021

Identifiers

DOI

10.1038/KI.2012.288

1 reference

13 September 2017

1 reference